Hellstrom-Lindberg, E., Gulbrandsen, N., Lindberg, G., Ahlgren, T., Dahl, I.M., Dybedal, I., et al., Scandinavian MDS Group (2003) A Validated Decision Model for Treating the Anaemia of Myelodysplastic Syndromes with Erythropoietin + Granulocyte Colony-Stimulating Factor: Significant Effects on Quality of Life. British Journal of Haematology, 120, 1037-1046.
http://dx.doi.org/10.1046/j.1365-2141.2003.04153.x

has been cited by the following article:

• TITLE: Quantification of the Erythropoietic Response to Anemia and Determination of the Hb × log(Epo) Component as an Independent Parameter, Indicating the Response to Hypoxic Stress

  AUTHORS: Argiris Symeonidis, Alexandra Kouraklis-Symeonidis, Vassiliki Labropoulou, Vasileios Lazaris, Paraskevi Katsaouni, Evgenia Verigou, Trifon Spiridonidis, Evangelia Tzouvara, Maria Tiniakou, Dimitris Apostolopoulos, Michalis Leotsinidis

  KEYWORDS: Erythropoietin, Hemoglobin, Anemia, Hypoxia, Response to Anemia

  JOURNAL NAME: Journal of Biomedical Science and Engineering, Vol.9 No.10, September 20, 2016

  ABSTRACT: Serum erythropoietin (Epo) levels are influenced by the integrity of renal function, the severity and etiology of anemia, the percentage of hemoglobin F and other factors. We aimed to create a parametric expression for the response to anemic/hypoxic stress and we evaluated serum Epo levels in 1096 subjects with normal renal function, of whom 837 were anemic (Hb 16.5 g/dl). Hb ranged between 3.6 and 23.8 g/dl and the corresponding Epo between